SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer Cells
Oxaliplatin is a commonly used chemotherapeutic drug for the treatment of pancreatic cancer. Understanding the cellular mechanisms of oxaliplatin resistance is important for developing new strategies to overcome drug resistance in pancreatic cancer. In this study, we performed a stable isotope label...
Main Authors: | Young Eun Kim, Eun-Kyung Kim, Min-Jeong Song, Tae-Young Kim, Ho Hee Jang, Dukjin Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/4/724 |
Similar Items
-
Quantitative Analysis of Differential Proteome Expression in Epithelial-to-Mesenchymal Transition of Bladder Epithelial Cells Using SILAC Method
by: Ganglong Yang, et al.
Published: (2016-01-01) -
A SILAC-Based Approach Elicits the Proteomic Responses to Vancomycin-Associated Nephrotoxicity in Human Proximal Tubule Epithelial HK-2 Cells
by: Zhi-Ling Li, et al.
Published: (2016-01-01) -
SILAC-based quantitative proteomic analysis of Drosophila gastrula stage embryos mutant for fibroblast growth factor signalling
by: Hamze Beati, et al.
Published: (2020-10-01) -
Oxaliplatin-induced Sudden Hearing Loss in a Patient with Pancreatic Cancer
by: Sung Bum Kim, et al.
Published: (2020-11-01) -
Age-dependent changes in protein incorporation into collagen-rich tissues of mice by in vivo pulsed SILAC labelling
by: Yoanna Ariosa-Morejon, et al.
Published: (2021-09-01)